RT Journal Article SR Electronic T1 Dual Time Point 18F-FDG PET for the Evaluation of Pulmonary Nodules JF Journal of Nuclear Medicine JO J Nucl Med FD Society of Nuclear Medicine SP 871 OP 875 VO 43 IS 7 A1 Alexander Matthies A1 Marc Hickeson A1 Andrew Cuchiara A1 Abass Alavi YR 2002 UL http://jnm.snmjournals.org/content/43/7/871.abstract AB 18F-FDG PET has reached widespread application in the assessment of pulmonary nodules. This study compares the diagnostic accuracy of standard 18F-FDG PET scanning with those of dual time point 18F-FDG PET scanning. Methods: Thirty-six patients (21 women, 15 men; mean age, 67 y; range, 36–88 y) with 38 known or suspected malignant pulmonary nodules underwent PET of the thorax at 2 time points: scan 1 at 70 min (range, 56–110 min) and scan 2 at 123 min (range, 100–163 min) after the intravenous injection of 2.5 MBq 18F-FDG per kilogram of body weight. All scanning was performed on a dedicated C-PET scanner. The mean interval between the scans was 56 min (range, 49–64 min). Regions of interest were overlaid onto each fully corrected image in the areas of the radiographically known lung densities. The standardized uptake values (SUVs) were calculated for both time points. Results: Surgical pathology and follow-up revealed 19 patients with 20 malignant tumors, whereas 16 patients had benign lesions. The tumor SUVs (mean ± SD) were 3.66 ± 1.95 (scan 1) and 4.43 ± 2.43 (scan 2) (20.5% ± 8.1% increase; P < 0.01). Four of 20 malignant tumors had SUVs of <2.5 on scan 1 (range, 1.12–1.69). Benign lesions had SUVs of 1.14 ± 0.64 (scan 1) and 1.11 ± 0.70 (scan 2) (P = not significant). Standard PET scanning (single time point) with a threshold SUV of 2.5 (at time point 1) reached a sensitivity of 80% and a specificity of 94%; dual time point scanning with a threshold value of 10% increase between scan 1 and scan 2 reached a sensitivity of 100% with a specificity of 89%. Conclusion: Dual time point 18F-FDG PET results in a very high sensitivity and specificity for detection of malignant lung tumors.